Pulmonary Complications Following Lung Resection* a Comprehensive Analysis of Incidence and Possible Risk Factors
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Thoracic Actinomycosis P
Thorax (1973), 28, 73. Thoracic actinomycosis P. R. SLADE, B. V. SLESSER, and J. SOUTHGATE Groby Road Hospital, Leicester Six cases of pulmonary infection with Actinomyces Israeli and one case of infection with Nocardia asteroides are described. The incidence of thoracic actinomycosis has declined recently and the classical presentation with chronic discharging sinuses is now uncommon. The cases described illustrate some of the forms which the disease may take. Actinomycotic infection has been noted, not infrequently, to co-exist with bronchial carcinoma and a case illustrating this association is described. Sputum cytology as practised for the diagnosis of bronchial carcinoma has helped to identify the fungi in the sputum. Treatment is discussed, particularly the possible use of oral antibiotics rather than penicillin by injection. Actinomycosis is not common in this country. showed only submucosal fibrosis. Cytological exam- The Table shows the number of cases reported to ination of the sputum showed the presence of fungus Health Laboratory Service from public (Figs 2 and 3) and cultures gave a growth of the Public Actinomyces Israeli. The patient was hypersensitive to health and hospital laboratories in the United penicillin and was treated with oral tetracycline, 2 g Kingdom and Republic of Ireland in recent years. daily for six months. There was marked reduction It is usually considered that the chest may be in the shadowing on the chest film after only six involved in about 15% of cases (Cecil and Loeb, weeks of treatment (Fig. 4) and subsequently com- 1963). But, of the 36 cases reported in 1970, the plete disappearance. The patient has remained well chest was involved in only one case. -
Quantitative Sputum Culture As a Means of Excluding False Positive Reports in the Routine Microbiology Laboratory
J Clin Pathol: first published as 10.1136/jcp.25.8.697 on 1 August 1972. Downloaded from J. clin. Path., 1972, 25, 697-700 Quantitative sputum culture as a means of excluding false positive reports in the routine microbiology laboratory M. J. B. WILSON AND D. E. MARTIN From the Department of Microbiology, Royal Perth Hospital, Perth, Western Australia SYNOPSIS A relatively simple technique for sputum homogenization and dilution is described. Results show that this technique is reliable for isolation and quantitative culture of organisms from cases of chest infection. The technique has resulted in significant reduction in false positive reports, particularly when a system of interpretative reporting is utilized based on 107 organisms per millilitre of sputum being accepted as evidence of significant infection. The bacteriology of human excretions, particularly A critical analysis of sputum culture results from sputum and urine, has given rise to considerable our laboratory showed that there was frequently a difficulties in interpretation. Kass (1957) contributed good growth of a potential pathogen when clinical much to the better understanding of the significance evidence for infection was equivocal and there was a of non-catheter urine culture when he introduced the tendency for the laboratory to make an excessive copyright. concept of colony counts, in an effort to distinguish number of false positive reports using standard between infected urine and urine from normal culture methods. These false positive reports are persons contaminated by urethral flora. Lower misleading and make it difficult to manage cases respiratory tract infections may likewise show a effectively, and they may lead to unwarranted and heavy growth of commensal organisms, because of undesirable antibiotic usage. -
Specimen Collection: Sputum (Home Health Care) - CE
Specimen Collection: Sputum (Home Health Care) - CE ALERT Don appropriate personal protective equipment (PPE) based on the patient’s signs and symptoms and indications for isolation precautions. Bronchospasm or laryngospasm, as a result of suctioning, can be severe and prolonged, and, in some cases, can be life-threatening without intervention. OVERVIEW Sputum is produced by cells that line the respiratory tract. Although production is minimal in the healthy patient, disease processes can increase the amount or change the character of sputum. Examination of sputum aids in the diagnosis and treatment of many conditions such as bronchitis, bronchiectasis, tuberculosis (TB), pneumonia, and pulmonary abscess, or lung cancer.3 In many cases, suctioning is indicated to collect sputum from a patient who cannot spontaneously produce a sample for laboratory analysis. Suctioning may provoke violent coughing, induce vomiting, and result in aspiration of stomach contents. Suctioning may also induce constriction of the pharyngeal, laryngeal, and bronchial muscles. In addition, suctioning may cause hypoxemia or vagal overload, causing cardiopulmonary compromise and an increase in intracranial pressure. Sputum for cytology, culture and sensitivity, and acid-fast bacilli (AFB) are three major types of sputum specimens.3 Cytologic or cellular examination of sputum may identify aberrant cells or cancer. Sputum collected for culture and sensitivity testing can be used to identify specific microorganisms and determine which antibiotics are the most sensitive. The AFB smear is used to support a diagnosis of TB. A definitive diagnosis of TB also requires a sputum culture and sensitivity.3 Regardless of the test ordered, a sputum specimen should be collected first thing in the morning due to a greater accumulation of bronchial secretions overnight. -
Nonintubated Thoracoscopic Surgery Using Regional Anesthesia and Vagal Block and Targeted Sedation
Original Article Nonintubated thoracoscopic surgery using regional anesthesia and vagal block and targeted sedation Ke-Cheng Chen1,2, Ya-Jung Cheng3, Ming-Hui Hung3, Yu-Ding Tseng1, Jin-Shing Chen1,2 1Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin County, Taiwan; 2Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 3Department of Anesthesiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan Corresponding to: Dr. Jin-Shing Chen. Department of Surgery, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei, Taiwan. Email: [email protected]. Objective: Thoracoscopic surgery without endotracheal intubation is a novel technique for diagnosis and treatment of thoracic diseases. This study reported the experience of nonintubated thoracoscopic surgery in a tertiary medical center in Taiwan. Methods: From August 2009 through August 2013, 446 consecutive patients with lung or pleural diseases were treated by nonintubated thoracoscopic surgery. Regional anesthesia was achieved by thoracic epidural anesthesia or internal intercostal blockade. Targeted sedation was performed with propofol infusion to achieve a bispectral index value between 40 and 60. The demographic data and clinical outcomes were evaluated by retrospective chart review. Results: Thoracic epidural anesthesia was used in 290 patients (65.0%) while internal intercostal blockade was used in 156 patients (35.0%). The final diagnosis were primary lung cancer in 263 patients (59.0%), metastatic lung cancer in 38 (8.5%), benign lung tumor in 140 (31.4%), and pneumothorax in 5 (1.1%). The median anesthetic induction time was 30 minutes by thoracic epidural anesthesia and was 10 minutes by internal intercostal blockade. -
Your Lung Operation Booklet
1 AMERICAN COLLEGE OF SURGEONS DIVISION OF EDUCATION SURGICAL PATIENT EDUCATION Table of Contents Welcome ...................................................................................1 Your Lungs ...............................................................................2 Lung Cancer ...........................................................................3 SURGICAL Understanding Your Operation ........................................4 PATIENT Preoperative Tests ................................................................5 EDUCATION Home Preparation ................................................................8 The Day of Your Operation ...............................................13 After Your Operation ..........................................................14 Your Recovery and Discharge .........................................17 When to Call Your Doctor .................................................19 Welcome You and your family are important members of the surgical team. The American College of Surgeons (ACS) “Your Lung Operation: Education for a Better Recovery” program will help you prepare for your operation and recovery. You and your family will know what to expect. You will learn how to work with your surgical team to ensure that you have the best surgical outcomes. COMPLETE THE “YOUR LUNG OPERATION” EDUCATION PROGRAM: Watch the DVD Read the booklet Review the Medication List and Quit Smoking Resources (inside front cover) Complete the Activity Log (inside front cover) Send us your evaluation after -
11736 Lab Req Red-Blue
3550 W. Peterson Ave., Ste. 100 ACCOUNT: Chicago, Illinois 60659 Tel: 773-478-6333 Fax: 773-478-6335 LABORATORY REQUISITION PATIENT NAME - LAST FIRST MIDDLE INITIAL PATIENT IDENTIFICATION SOCIAL SECURITY NO. DATE OF BIRTH SEX N O I NAME OF INSURED SS# OF INSURED RELATIONSHIP TO PATIENT T A M R O PATIENT/INSURED ADDRESS PHONE NUMBER MEDICARE NO. (INCLUDING ALPHA CHARACTERS) F Please attach an ABN form. N I G N CITY STATE ZIP CODE I L L I MEDICAID NO. B BILL I PHYSICIAN I PATIENT I MEDICARE I MEDICAID I INSURANCE (attach copy of both sides of card) TO ACCOUNT DIAGNOSIS (CD-9 CODE(S)) (REQUIRED FOR 3RD PARTY BILLING) PLEASE WRITE PATIENT’S NAME ON ALL SPECIMENS DATE COLLECTED COLLECTED BY AM DR. NAME / NPI # DR. OR RN SIGNATURE PM 001 GENERAL HEALTH PROFILE ( Male ) - CBC, CMP, LIPID, TSH, FT4, TT3, FERRITIN, PSA, H-PYLORI, MAG, ESR, UA, IRON/TIBC SST, L, U 002 GENERAL HEALTH PROFILE ( Female ) - CBC, CMP, LIPID, TSH, FT4, TT3, FERRITIN, H-PYLORI, MAG, ESR, UA, IRON/TIBC SST, L, U 003 AMENOR/MENSTR. DISORDER - CMP, LIPID, CBC, TSH, FT4, TT3, ESR, IRON/TIBC, FERRITIN, MAG, UA, HCG, FSH, LH, PROLACTIN, RET COUNT SST, L, U 004 ANEMIA - CMP, LIPID, IRON/TIBC, CBC, FERRITIN, TSH, FT4, TT3, H-PYLORI, UA, G6PD, RET COUNT SST, L, U 005 ARTHRITIS - CMP, LIPID, CBC, URIC ACID, ESR, ASO, CRP, ANA, RH, SLE SST, L, U 006 DIABETES - CMP, LIPID, CBC, HBA1C, CORTISOL, TSH, FT4, TT3, UA, RET COUNT SST, L, U 007 HEPATITIS - HAAB IGM, HBCAB IGM, HBSAB, HBSAG, HCAB, SGOT, SGPT SST 008 HYPERTENSION/CARDIAC - CMP, LIPID, CBC, TSH, FT4, TT3, IRON/TIBC, CPK, CORTISOL, -
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
SURGICAL INFECTIONS Volume 14, Number 1, 2013 Surgical Infection Mary Ann Liebert, Inc. DOI: 10.1089/sur.2013.9999 Society Guidelines Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery Dale W. Bratzler,1 E. Patchen Dellinger,2 Keith M. Olsen,3 Trish M. Perl,4 Paul G. Auwaerter,5 Maureen K. Bolon,6 Douglas N. Fish,7 Lena M. Napolitano,8 Robert G. Sawyer,9 Douglas Slain,10 James P. Steinberg,11 and Robert A. Weinstein12 hese guidelines were developed jointly by the Ameri- the project. Panel members and contractors were required to Tcan Society of Health-System Pharmacists (ASHP), the disclose any possible conflicts of interest before their ap- Infectious Diseases Society of America (IDSA), the Surgical pointment and throughout the guideline development pro- Infection Society (SIS), and the Society for Healthcare Epide- cess. Drafted documents for each surgical procedural section miology of America (SHEA). This work represents an update were reviewed by the expert panel and, once revised, were to the previously published ASHP Therapeutic Guidelines on available for public comment on the ASHP website. After Antimicrobial Prophylaxis in Surgery [1], as well as guide- additional revisions were made to address reviewer com- lines from IDSA and SIS [2,3]. The guidelines are intended to ments, the final document was approved by the expert panel provide practitioners with a standardized approach to the and the boards of directors of the above-named organizations. rational, safe, and effective use of antimicrobial agents for the prevention of surgical site infections (SSIs) based on currently Strength of evidence and grading of recommendations available clinical evidence and emerging issues. -
Antimicrobial Treatment Guidelines for Common Infections
Antimicrobial Treatment Guidelines for Common Infections March 2019 Published by: The NB Provincial Health Authorities Anti-infective Stewardship Committee under the direction of the Drugs and Therapeutics Committee Introduction: These clinical guidelines have been developed or endorsed by the NB Provincial Health Authorities Anti-infective Stewardship Committee and its Working Group, a sub- committee of the New Brunswick Drugs and Therapeutics Committee. Local antibiotic resistance patterns and input from local infectious disease specialists, medical microbiologists, pharmacists and other physician specialists were considered in their development. These guidelines provide general recommendations for appropriate antibiotic use in specific infectious diseases and are not a substitute for clinical judgment. Website Links For Horizon Physicians and Staff: http://skyline/patientcare/antimicrobial For Vitalité Physicians and Staff: http://boulevard/FR/patientcare/antimicrobial To contact us: [email protected] When prescribing antimicrobials: Carefully consider if an antimicrobial is truly warranted in the given clinical situation Consult local antibiograms when selecting empiric therapy Include a documented indication, appropriate dose, route and the planned duration of therapy in all antimicrobial drug orders Obtain microbiological cultures before the administration of antibiotics (when possible) Reassess therapy after 24-72 hours to determine if antibiotic therapy is still warranted or effective for the given organism -
The Role of Surgery in the Treatment of Pulmonary TB and Multidrug- and Extensively Drug-Resistant TB
The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB ABSTRACT The global spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of M. tuberculosis have resulted in a resurgence of almost incurable and even fatal cases for which only a few therapeutic options are available. Surgery has been applied to improve treatment success rates in MDR-TB patients and a combined medical and surgical approach is increasingly being used to treat patients with M/XDR-TB. The effectiveness of surgery in the management of pulmonary TB (particularly MDR-TB) has not, however, been documented and evaluated, its role in the Tuberculosis Control Programme is not well-established and practices vary across the WHO European Region. The WHO Regional Office for Europe has decided, in collaboration with the Member States and other partners, to review existing practices and lessons learned and to document expert opinion based on the available evidence and consensus among the members of the European Task Force on the role of Surgery in MDR- TB. This consensus paper should not be considered as recommendations from WHO but as a document of expert opinion based on current evidence, which presents indications and contraindications for surgical treatment of pulmonary TB and M/XDR-TB, the conditions for and timing of surgery, types of operation, and preoperative and postoperative management. Keywords POSTOPERATIVE CARE SURGERY TUBERCULOSIS, EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, MULTIDRUG-RESISTANT TUBERCULOSIS, PULMONARY Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe UN City, Marmorvej 51 DK-2100 Copenhagen Ø, Denmark Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office website (http://www.euro.who.int/pubrequest). -
Sublobectomy Is a Safe Alternative for Localized Cavitary Pulmonary
Yang et al. Journal of Cardiothoracic Surgery (2021) 16:22 https://doi.org/10.1186/s13019-021-01401-5 RESEARCH ARTICLE Open Access Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis Yong Yang1†, Shaojun Zhang2†, Zhengwei Dong3, Yong Xu1, Xuefei Hu1, Gening Jiang1, Lin Fan2* and Liang Duan1* Abstract Objective: Surgical resection plays an essential role in the treatment of Pulmonary Tuberculosis (PTB). There are few reports comparing lobectomy and sublobectomy for pulmonary TB with cavity. To compare the advantages between lobectomy and sublobectomy for localized cavitory PTB, we performed a single-institution cross sectional cohort study of the surgical patients. Methods: We consecutively included 203 patients undergoing lobectomy or sublobectomy surgery for localized cavitary PTB. All patients were followed up, recorded and compared their surgical complication, outcome and associated characteristics. Results: Both groups had similar outcomes after follow up for 13.1 ± 12.1 months, however, sublobectomy group suffered fewer intraoperative blood losses, shorter length of stay, and fewer operative complications than lobectomy group (P < 0.05). Both groups obtained satisfactory outcome with postoperatively medicated for similar period of time and few relapse (P > 0.05). Conclusion: Both sublobectomy and lobectomy resection were effective ways for cavitary PTB with surgical indications. If adequate anti-TB chemotherapy had been guaranteed, sublobectomy is able to be recommended due to more lung parenchyma retain, faster recover, and fewer postoperative complications. Keywords: Pulmonary tuberculosis, Cavity, Lobectomy, Sublobectomy, Complication, Prognosis Introduction observed in clinic. It accounts for more than 40% of Tuberculosis (TB) is still a major public health threat adults with PTB [3, 4]. -
Both Left Upper Lobectomy and Left Pneumonectomy Are Risk Factors For
www.nature.com/scientificreports OPEN Both left upper lobectomy and left pneumonectomy are risk factors for postoperative stroke Received: 12 December 2018 Nanchang Xie1, Xianghe Meng1, Chuanjie Wu2, Yajun Lian1, Cui Wang3, Mengyan Yu1, Accepted: 8 July 2019 Yingjiao Li1 & Yali Wang1 Published: xx xx xxxx Retrospective studies have found that left upper lobectomy (LUL) may be a new risk factor for stroke, and the potential mechanism is pulmonary vein thrombosis, which more likely develops in the left superior pulmonary vein (LSPV) stump. The LSPV remaining after left pneumonectomy is similar to that remaining after LUL. However, the association between left pneumonectomy, LUL, and postoperative stroke remains unclear. Thus, we sought to analyze whether both LUL and left pneumonectomy are risk factors for postoperative stroke. We prospectively included consecutive patients who underwent resection between November 2016 and March 2018 at our institution with 6 months of follow-up. Baseline demographic and clinical data were taken. A logistic regression model was used to determine independent predictors of postoperative stroke. In our study, 756 patients who underwent an isolated pulmonary lobectomy procedure were screened; of these, 637 patients who completed the 6-month follow-up were included in the analysis. Multivariable logistic regression analysis adjusted for common risk factors showed that the LUL and left pneumonectomy were independent predictors of stroke (odds ratio, 18.12; 95% confdence interval, 2.12–155.24; P = 0.008). Moreover, diabetes mellitus also was a predictor of postoperative stroke. In conclusion, both LUL and left pneumonectomy are signifcant risk factors for postoperative stroke. Stroke is one of the most feared complications of surgery, which occurs in 0.08–0.7% and 0.6% of general and thoracic surgery patients, respectively1–3. -
Answer Key Chapter 1
Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6.